Frequency and duration of Ursodeoxycholic acid 450mg tablets for increase bilirubin case and the value of increased bilirubin is 2.2 ?
Reading File
Finding Sources
Searching the Web
ursodeoxycholic acid UDCA 450mg dosing frequency duration elevated bilirubin
Finding Sources
Here is a clear, evidence-based answer for UDCA 450 mg tablets in a case of mildly elevated bilirubin (2.2 mg/dL):
Ursodeoxycholic Acid (UDCA) 450 mg - Dosing for Elevated Bilirubin
Context - What Is Bilirubin 2.2 mg/dL?
A total bilirubin of 2.2 mg/dL is mildly elevated (normal: 0.2-1.2 mg/dL). This level suggests early/mild cholestatic liver disease, intrahepatic cholestasis, or conditions like Primary Biliary Cholangitis (PBC), intrahepatic cholestasis of pregnancy (ICP), or non-alcoholic fatty liver disease with cholestasis. UDCA is indicated when the cause is cholestatic in nature.
Standard UDCA Dosing (Evidence-Based)
The universally accepted dose is 13-15 mg/kg/day (EASL, AASLD, BSG guidelines; confirmed in Goldman-Cecil Medicine: "Ursodeoxycholic acid therapy (12 to 15 mg/kg/day) improves serum bilirubin, alkaline phosphatase, and cholesterol levels").
UDCA 450 mg Tablet - Frequency by Body Weight:
| Body Weight | Total Daily Dose (13-15 mg/kg) | 450 mg Tablets | Regimen |
|---|---|---|---|
| 50-60 kg | 650-900 mg/day | 1.5-2 tablets | 1 tablet twice daily (BD) |
| 60-70 kg | 780-1050 mg/day | 2 tablets | 1 tablet twice daily (BD) |
| 70-80 kg | 910-1200 mg/day | 2 tablets | 1 tablet twice daily (BD) |
| 80-90 kg | 1040-1350 mg/day | 3 tablets | 1 tablet three times daily (TDS) |
| >90 kg | >1170 mg/day | 3 tablets | 1 tablet three times daily (TDS) |
Most common prescription for average adult (60-80 kg): UDCA 450 mg - 1 tablet twice daily (BD)
Duration of Treatment
The duration depends on the underlying cause:
| Condition | Duration |
|---|---|
| Primary Biliary Cholangitis (PBC) | Lifelong - treatment should never be stopped even if bilirubin normalizes, as normalization means it is working |
| Intrahepatic Cholestasis of Pregnancy (ICP) | Until delivery (typically from diagnosis ~28-32 weeks until delivery), then reassess; usually stopped postpartum once labs normalize |
| Cholestatic hepatitis / NAFLD with cholestasis | 3-6 months minimum; continue if response seen, reassess periodically |
| Drug-induced cholestasis | Until the offending drug is removed and liver tests normalize (weeks to months) |
| Gallstone dissolution | 6-24 months until dissolution confirmed on ultrasound |
Key Points
- Take with food to improve absorption (preferably with the main meals or at bedtime)
- Monitor liver function tests (LFTs) including bilirubin at 1 month, then every 3-6 months
- A bilirubin of 2.2 mg/dL is mild - response to UDCA is typically good at this stage; expect improvement in bilirubin within 3-6 months of treatment
- If bilirubin does not improve after 3-6 months of adequate UDCA dosing, re-evaluate the diagnosis and consider adding second-line agents (obeticholic acid for PBC)
- In pregnancy-related cholestasis (ICP), the standard dose is slightly higher: 15-20 mg/kg/day
Typical prescription written:
Ursodeoxycholic Acid 450 mg - 1 tablet twice daily (BD) with meals - Duration: as per underlying diagnosis (minimum 3-6 months for cholestatic disease; lifelong for PBC)
Important note: The exact frequency and duration must be determined by the treating physician based on the patient's weight, underlying diagnosis, and treatment response. This is guidance only - not a substitute for clinical judgment.
This is a shared conversation. Sign in to Orris to start your own chat.